A Randomized, Single-Blind, Multicenter Study Comparing Pixantrone + Rituximab with an Investigator’s Choice of Single Agent Rituximab or Gemcitabine + Rituximab in Non-Stem Cell Transplant Eligible Patients with Aggressive B-cell Non-Hodgkins Lymphoma Who Have Relapsed after Therapy with CHOP-R or an Equivalent Regimen

Type of Cancer
Lymphoma

Site
Bethesda

Protocol Number
PIX306

To Learn More Call
201-510-0910